Pharmacology of the Equine Foot
Authors:
- 1 December 2021
- journal article
- research article
- Published by Elsevier in Veterinary Clinics of North America: Equine Practice
- Vol. 37 (3) , 549-561
Abstract
No abstract availableKeywords
This publication has 72 references indexed in Scilit:
- Acute augmentation of epoxygenated fatty acid levels rapidly reduces pain-related behavior in a rat model of type I diabetesProceedings of the National Academy of Sciences, 2012
- Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociceptionProstaglandins & Other Lipid Mediators, 2011
- Naturally occurring monoepoxides of eicosapentaenoic acid and docosahexaenoic acid are bioactive antihyperalgesic lipidsJournal of Lipid Research, 2010
- Epoxygenated Fatty Acids and Soluble Epoxide Hydrolase Inhibition: Novel Mediators of Pain ReductionJournal of Agricultural and Food Chemistry, 2010
- EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEuropean Journal of Neurology, 2010
- Mechanisms of Non-Opioid Analgesics Beyond Cyclooxygenase Enzyme InhibitionCurrent Molecular Pharmacology, 2009
- Soluble epoxide hydrolase and epoxyeicosatrienoic acids modulate two distinct analgesic pathwaysProceedings of the National Academy of Sciences, 2008
- Antinociception Produced by 14,15-Epoxyeicosatrienoic Acid Is Mediated by the Activation of β-Endorphin and Met-Enkephalin in the Rat Ventrolateral Periaqueductal GrayThe Journal of Pharmacology and Experimental Therapeutics, 2008
- Non-redundant Functions of Cyclooxygenases: Oxygenation of EndocannabinoidsJournal of Biological Chemistry, 2008
- The contribution of cyclooxygenase‐2 to endocannabinoid metabolism and actionBritish Journal of Pharmacology, 2007